The paper tests empirically the role of knowledge stocks to explain the regional distribution of Germany's biotechnology founders. We present an unique approach to highlight the role of knowledge spillovers as we differentiate according the local embeddedness and research affinity of founders....

The goal of this paper is to point out the role played by private equity investors (venture-capital companies and corporate investors) in the emergence of a new biotechnology industry in Germany in the second half of the 90's. This analysis takes into account the different business models and...

Previous studies argued that low investment-cash flow sensitivities of German firms may be caused by dominance of public banking. The paper addresses this topic and applies a unique accounting dataset of German firms. Results from a dynamic panel data approach show that the dependence of...

Bernhard Lageman, Christoph M. Schmidt, Dirk Engel und Michael Rothgang Der Lissabon-Prozess: Anspruch und Realität Forschung und Entwicklung in Nordrhein-Westfalen Duncker & Humblot • Berlin Inhaltsverzeichnis Herausforderungen des Barcelona-Ziels für...

In this paper, we evaluate the R&D enhancing effects of two large public grant schemes aiming at encouraging the performance of firms organized in clusters. These are Germany's well known BioRegio and BioProfile contests for which we compare the research performance of winning regions in...